JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -0.1% · netto nieuwe posities -3.6% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.17B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 236.62M | -0.2% | $43.87B | 0.7% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 207.26M | +1.7% | $38.43B | 0.7% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passief) | 132.21M | -0.5% | $24.51B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 117.28M | — | $21.75B | 0.7% | n/c | 1 | SEC ↗ ×46 |
| 5 | Geode Capital Management ✦ (passief) | 56.22M | -7.2% | $10.39B | 0.7% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 48.23M | — | $8.94B | 0.5% | n/c | 1 | SEC ↗ ×20 |
| 7 | Wellington Management ✦ | 25.83M | +3.8% | $4.79B | 0.8% | ▲ Add | 6 | SEC ↗ ×8 |
| 8 | Fidelity (FMR) ✦ | 13.44M | +0.2% | $2.49B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 9 | Goldman Sachs Group ✦ | 13.11M | — | $2.43B | 0.4% | n/c | 1 | SEC ↗ ×6 |
| 10 | T. Rowe Price ✦ | 8.77M | +4.7% | $1.63B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Fisher Asset Management ✦ | 8.45M | +2.1% | $1.57B | 0.6% | ▲ Add | 6 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 4.33M | -9.8% | $793.04M | 0.5% | ▼ Trim | 6 | SEC ↗ ×7 |
| 13 | Marshall Wace ✦ | 3.58M | +126.3% | $664.58M | 0.7% | ▲ Add | 6 | SEC ↗ ×3 |
| 14 | Arrowstreet Capital ✦ | 2.31M | -5.9% | $429.15M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 2.26M | +69.4% | $419.73M | 0.7% | ▲ Add | 6 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 1.72M | -24.8% | $318.14M | 1.2% | ▼ Trim | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 1.33M | +138.6% | $246.64M | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | D. E. Shaw & Co. ✦ | 1.14M | -59.8% | $212.06M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Two Sigma Investments ✦ | 925.29K | +422.8% | $171.57M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 20 | Millennium Management ✦ | 628.66K | -40.3% | $116.57M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Markel Group ✦ | 610.80K | 0.0% | $113.25M | 0.9% | Held | 6 | SEC ↗ ×2 |
| 22 | Renaissance Technologies ✦ | 306.75K | -65.3% | $56.88M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 23 | Tweedy, Browne ✦ | 242.00K | -1.1% | $44.87M | 3.9% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 213.04K | +15.6% | $39.50M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 82.38K | -4.9% | $15.27M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 26 | Fairfax Financial ✦ | 73.40K | 0.0% | $13.61M | 0.7% | Held | 6 | SEC ↗ |
| 27 | Dodge & Cox ✦ | 20.95K | 0.0% | $3.88M | 0.0% | Held | 6 | SEC ↗ |
| 28 | Point72 Asset Management ✦ | 7.39K | -98.7% | $1.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Norges Bank | $4.88B | was 0.6% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 136.10K aandelen, $33,268 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 11.07K aand · $3.04M
Officer · 22.53K aand · $6.19M
Officer · 15.00K aand · $3.95M
Officer, Director · 102.31K aand · $26.70M
Officer, Director · 20.98K aand · $5.50M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie